Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hypertension × Endocrine × Clear all

Status

Completed 6 Recruiting 3 Active not recruiting 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 3 Breast 3 Other 2 Lymphoid 2 Dermatologic 2 Classical hematology 2 Thoracic 1 Other hematologic neoplasm 1 Gynecologic 1 Gastrointestinal 1 Endocrine 1 CNS 1

Conditions

Neuroendocrine Tumors 66 Pituitary Neoplasms 45 Thyroid Cancer, Papillary 22 Multiple Endocrine Neoplasia Type 1 20 Carcinoma, Neuroendocrine 19 Pheochromocytoma 16 Paraganglioma 13 Thyroid Neoplasms 12 Neoplasm Metastasis 12 Differentiated Thyroid Cancer 12 Carcinoid Tumor 12 Adrenocortical Carcinoma 11 Neoplasms 10 Adrenal Gland Neoplasms 8 Thyroid Carcinoma, Anaplastic 7 Pancreatic Neoplasms 7 Insulinoma 7 Pituitary Diseases 6 Lung Neoplasms 6 Acromegaly 6 Stomach Neoplasms 5 Prostatic Neoplasms 5 Prolactinoma 5 Gastro-enteropancreatic neuroendocrine tumor 5 Carcinoma, Hepatocellular 5 Adenoma, Islet Cell 5 Small Cell Lung Carcinoma 4 Recurrence 4 Melanoma 4 Lymphatic Metastasis 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02772315 2017-01-26

ENSAT-HT

Radboud University Medical Center

Hyperaldosteronism, Hypertension, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡